CK Life Sciences Intl (Holdings) Inc → TransCode Therapeutics, Inc. RNAZ

Stake: — Shares: 300,040 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 1.51

30,910 shares short · +9.4% vs prior

Other 13D/G Filings on TransCode Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-03	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	83.90%	14,134,481	view →
2026-07-27	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	83.90%	14,134,481	view →
2026-07-17	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	8.80%	83,285	view →
2023-10-10	SC	Dudley Robert Michael	—	—	view →

Other Filings by CK Life Sciences Intl (Holdings) Inc

Filed	Form	Issuer	Stake	Shares
2026-08-03	SCHEDULE 13D/A	TransCode Therapeutics, Inc.	83.90%	14,134,481	view →
2026-07-27	SCHEDULE 13D/A	Transcode Therapeutics, Inc.	83.90%	14,134,481	view →
2026-07-17	SCHEDULE 13D/A	TransCode Therapeutics, Inc.	8.80%	83,285	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →